{
    "2019-05-14": [
        [
            {
                "time": "",
                "original_text": "泰格医药为参股公司担保1320万元 所属企业拟香港IPO",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "担保",
                        "参股公司",
                        "香港IPO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【华泰医药代雯团队】医药行业2019年中期策略：屈盘侧白马，劈浪把龙头",
                "features": {
                    "keywords": [
                        "华泰医药",
                        "中期策略",
                        "医药行业",
                        "白马股",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：Frontage Holdings Corporation联交所主板上市申请获同意",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "Frontage Holdings Corporation",
                        "联交所",
                        "主板上市",
                        "申请同意"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：副总经理ZHUANYIN已减持175万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "副总经理",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "5月14日",
                "original_text": "A股共发生47宗大宗交易 成交12.37亿元（5月14日）",
                "features": {
                    "keywords": [
                        "A股",
                        "大宗交易",
                        "成交额"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：高级管理人员减持0.35%股份 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "高级管理人员",
                        "减持",
                        "股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药今日大宗交易成交175万股，成交价60.08元折价8.6%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "大宗交易",
                        "成交价",
                        "折价"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药研发费仅占营收2% 分拆方达控股冲关香港IPO",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "研发费",
                        "营收占比",
                        "分拆",
                        "方达控股",
                        "香港IPO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "MSCI：纳入的26只中国A股股票中，有18只来自创业板",
                "features": {
                    "keywords": [
                        "MSCI",
                        "中国A股",
                        "创业板",
                        "纳入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}